Phase 2 Fabry Disease Clinical Trial Has Been Stopped Due to Negative Outcomes
Avrobio has just announced that they will be stopping work on their investigative gene therapy for Fabry disease based on unexpected and disappointing results from a Phase 2 clinical trial.…